Benchmark

According to a research report published earlier today, Benchmark has upgraded True Religion Apparel (NASDAQ: TRLG) from Neutral to Buy. In the report, Benchmark said, “We believe spring fashion has been well received with lots of color, even colored denim. While we believe the unseasonably warm...

According to a research report published earlier today, Benchmark has increased Rackspace Hosting's (NYSE: RAX) PT from $60 to $66. In the report, Benchmark said, “As one of the founders of the open-sourced cloud platform OpenStack, Rackspace could benefit from increased visibility and momentum of...

According to a research report published earlier today, Benchmark has upgraded Liquidity Services (NASDAQ: LQDT) from Hold to Buy and has increased PT from $41 to $57. In the report, Benchmark commented, “We estimate F2Q (March) GMV may come in around $218 million, almost $50 million ahead of the...

According to a research report published today, Benchmark has lowered Groupon's (NASDAQ: GRPN) PT from $32 to $28. In the report, Benchmark stated, “Groupon revised down 4Q11 financial results. The change was due to greater refunds than anticipated as product mix has shifted to higher-priced deals...

Benchmark increases its target $7 to $82 on Hold-rated Dun & Bradstreet (NYSE: DNB) on expectations of a pickup in activity for the second half of 2012. Benchmark says, "For 1Q12, we expect revenue to be $396 million, up 2.5% y/y adjusted for last year's divestitures in Japan and China....

According to a research report published earlier today, Benchmark has initiated Cardiovascular Systems Inc. (NASDAQ: CSII) with a Speculative Buy rating and $15 PT. In the report, Benchmark commented, “CSII's initial focus is on the treatment of peripheral artery disease (PAD). CSII's products...

According to a research report published earlier today, Benchmark has increased McGraw-Hill Companies' (NYSE: MHP) PT from $48 to $52. In the report, Benchmark commented, “We are raising our 2012 revenue and EPS estimates for McGraw-Hill (MHP, Hold) mainly reflecting the recovery in bond issuance...

Benchmark initiates a Speculative Buy rating and a price target of $31 on Tornier NV (NASDAQ: TRNX). Benchmark notes, "We believe that TRNX is a market leader in the fast growing extremity market. We believe that TRNX has the number two position worldwide for sales of shoulder joint replacement...

Benchmark raises its price target to $33 on Buy-rated Progress Software (NASDAQ: PRGS) following a preview to F1Q12. Benchmark says, " PRGS is set to report F1Q12 results on Wednesday, March 28. We estimate total revenue of $120 million and EPS of $0.25, relatively in line with the First Call...

According to a research report published earlier today, Benchmark has upgraded Saba Software Inc. (NASDAQ: SABA) from Hold to Buy, and establishes a target price of $16. In the report, Benchmark commented, “We are upgrading our rating on SABA to Buy from Hold and establishing a $16 price target...

According to a research report published earlier today, Benchmark has upgraded OpenTable Inc. (NASDAQ: OPEN) from Hold to Buy. Benchmark briefly commented in the report, “We upgrade OpenTable from Hold to Buy due to superior growth and competitive position, improving economic trends and peer...

Benchmark raises its price target $8 to $45 on Hold-rated Moody's (NYSE: MCO) on improving bond issuance. Benchmark says, " We are raising our 2012 revenue and EPS estimates, mainly reflecting signs of a recovery in bond issuance along with strong growth prospects of Moody's Analytics." MCO...

Benchmark raises its price target $2 to $14 on Buy-rated Guidance Software (NASDAQ: GUID) on sector strength, improving momentum and the CaseCentral acquisition. Benchmark says, "We think this action is appropriate given the recent strength of the broad software sector, GUID's continuing momentum...

Benchmark raises its price target $8 to $49 on Buy-rated EZ Chip Semiconductor (NASDAQ: EZCH) on acceleration of carrier-grade equipment booking and NP-4 ramping. Benchmark says, "We are increasing our price target on shares of EZchip from $41 to $49 based on our increased confidence the company'...

According to a research report published earlier today, Benchmark has increased Synergetics USA Inc.'s (NASDAQ: SURG) PT from $7.50 to $8. In the report, Benchmark commented, “Synergetics reported solid results for F2Q, which ended in January. EPS expanded 40.3% to $0.07, which matched our...